The addition of Seagen in 2023 also strengthened its position in oncology by adding four ADCs — Adcetris, Padcev, Tukysa and Tivdak. The acquired Seagen products contributed meaningfully to ...

In this interview, Dr Usman Iqbal, head of Oncology Global Evidence &amp, Value Development at Sanofi, discusses market access in oncology and how to demonstrate value in this area in the US ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple ...

These MAs will speed up the export of multiple oncology products to the EU region manufactured at Sakar's state-of-the-art vertically integrated oncology product manufacturing site.

Please provide your email address to receive an email when new articles are posted on . More than half of study participants used personal care products that had formaldehyde or formaldehyde-releasing ...

Company News Published 06/05/2025, 08:49 AM 0 SELLAS adds oncology experts to advisory board SLS 12.31% ...

Oncology products have been the biggest beneficiary of breakthrough status so far - of the 10 approvals to date, the majority have been for cancer drugs. And in terms of oncology branding, it ...

The acquired Seagen products contributed meaningfully to Pfizer’s revenues in 2024 and in the first quarter of 2025. Seagen also has some next-generation ADC candidates in its pipeline.

NEW YORK - SELLAS Life Sciences Group, Inc. (NASDAQ: SLS), a biopharmaceutical company engaged in developing cancer therapies, announced today the expansion of its Scientific Advisory Board (SAB) with ...